Felicia Allard
Concepts (135)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intestinal Mucosa | 3 | 2020 | 259 | 1.350 |
Why?
| Nonprescription Drugs | 1 | 2019 | 42 | 0.690 |
Why?
| Gastric Mucosa | 1 | 2019 | 59 | 0.670 |
Why?
| Prescription Drugs | 1 | 2019 | 35 | 0.670 |
Why?
| Ampulla of Vater | 1 | 2018 | 17 | 0.660 |
Why?
| Cytodiagnosis | 1 | 2018 | 44 | 0.640 |
Why?
| Paranasal Sinus Neoplasms | 1 | 2018 | 27 | 0.640 |
Why?
| Dacryocystitis | 2 | 2015 | 5 | 0.610 |
Why?
| Carcinoma, Squamous Cell | 1 | 2018 | 384 | 0.500 |
Why?
| Crohn Disease | 3 | 2021 | 96 | 0.490 |
Why?
| Neoplasm Recurrence, Local | 1 | 2018 | 644 | 0.480 |
Why?
| Nasolacrimal Duct | 1 | 2013 | 10 | 0.470 |
Why?
| Anesthetics, Local | 1 | 2013 | 74 | 0.450 |
Why?
| Cocaine | 1 | 2013 | 184 | 0.420 |
Why?
| Gastrointestinal Agents | 2 | 2021 | 36 | 0.380 |
Why?
| Cocaine-Related Disorders | 1 | 2013 | 246 | 0.380 |
Why?
| Biopsy | 4 | 2020 | 692 | 0.350 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 240 | 0.330 |
Why?
| Dacryocystorhinostomy | 2 | 2015 | 9 | 0.250 |
Why?
| Suture Techniques | 2 | 2014 | 70 | 0.240 |
Why?
| Alanine Transaminase | 2 | 2023 | 151 | 0.230 |
Why?
| Liver Diseases | 1 | 2023 | 87 | 0.220 |
Why?
| Retrospective Studies | 7 | 2021 | 6432 | 0.210 |
Why?
| Biological Factors | 1 | 2021 | 13 | 0.200 |
Why?
| Endoscopy, Gastrointestinal | 2 | 2018 | 75 | 0.190 |
Why?
| Duodenal Neoplasms | 1 | 2020 | 15 | 0.190 |
Why?
| Biopsy, Fine-Needle | 2 | 2018 | 116 | 0.190 |
Why?
| Humans | 17 | 2021 | 54246 | 0.180 |
Why?
| Immunity, Innate | 1 | 2020 | 114 | 0.180 |
Why?
| Spinal Diseases | 1 | 2019 | 20 | 0.170 |
Why?
| Aged, 80 and over | 5 | 2020 | 3429 | 0.170 |
Why?
| Methamphetamine | 1 | 2022 | 233 | 0.170 |
Why?
| Blastomycosis | 1 | 2019 | 61 | 0.170 |
Why?
| Predictive Value of Tests | 2 | 2020 | 1048 | 0.170 |
Why?
| Claudin-1 | 1 | 2018 | 5 | 0.160 |
Why?
| Zonula Occludens-1 Protein | 1 | 2018 | 7 | 0.160 |
Why?
| Observer Variation | 1 | 2018 | 138 | 0.160 |
Why?
| Immunohistochemistry | 2 | 2018 | 1089 | 0.160 |
Why?
| Lumbar Vertebrae | 1 | 2019 | 105 | 0.160 |
Why?
| Magnetic Resonance Imaging | 2 | 2015 | 1604 | 0.160 |
Why?
| Cation Transport Proteins | 1 | 2018 | 28 | 0.160 |
Why?
| Oculomotor Muscles | 2 | 2014 | 31 | 0.150 |
Why?
| Sutures | 2 | 2014 | 45 | 0.150 |
Why?
| Eyelids | 2 | 2014 | 33 | 0.150 |
Why?
| Neoplasm Metastasis | 1 | 2018 | 252 | 0.150 |
Why?
| Cell Proliferation | 2 | 2018 | 1096 | 0.150 |
Why?
| Male | 10 | 2022 | 27312 | 0.140 |
Why?
| Adult | 6 | 2020 | 14182 | 0.140 |
Why?
| Colonic Pouches | 1 | 2015 | 6 | 0.140 |
Why?
| Adenomatous Polyposis Coli | 1 | 2015 | 8 | 0.140 |
Why?
| Pancreatic Cyst | 1 | 2015 | 13 | 0.140 |
Why?
| Colitis, Ulcerative | 1 | 2015 | 52 | 0.130 |
Why?
| Rectal Neoplasms | 1 | 2015 | 51 | 0.130 |
Why?
| Endosonography | 1 | 2015 | 96 | 0.130 |
Why?
| Pancreatic Neoplasms | 1 | 2018 | 234 | 0.130 |
Why?
| Ectropion | 1 | 2014 | 2 | 0.130 |
Why?
| Aged | 6 | 2020 | 10041 | 0.130 |
Why?
| Middle Aged | 7 | 2020 | 13070 | 0.130 |
Why?
| Enchondromatosis | 1 | 2014 | 1 | 0.120 |
Why?
| Entropion | 1 | 2014 | 2 | 0.120 |
Why?
| Reproducibility of Results | 1 | 2018 | 1304 | 0.120 |
Why?
| Chondrosarcoma | 1 | 2014 | 13 | 0.120 |
Why?
| Ophthalmologic Surgical Procedures | 1 | 2014 | 27 | 0.120 |
Why?
| Blepharoptosis | 1 | 2014 | 15 | 0.120 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2014 | 49 | 0.120 |
Why?
| Lacrimal Duct Obstruction | 1 | 2013 | 6 | 0.120 |
Why?
| Administration, Intranasal | 1 | 2013 | 29 | 0.120 |
Why?
| Bronchoscopy | 1 | 2014 | 79 | 0.120 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 866 | 0.120 |
Why?
| Azithromycin | 1 | 2013 | 42 | 0.120 |
Why?
| Fluoroquinolones | 1 | 2013 | 37 | 0.120 |
Why?
| Prognosis | 1 | 2018 | 2118 | 0.110 |
Why?
| Follow-Up Studies | 1 | 2018 | 2387 | 0.110 |
Why?
| Combined Modality Therapy | 1 | 2013 | 692 | 0.100 |
Why?
| Treatment Outcome | 5 | 2021 | 5604 | 0.100 |
Why?
| Rats, Wistar | 2 | 2022 | 237 | 0.090 |
Why?
| Female | 8 | 2020 | 28418 | 0.090 |
Why?
| Postoperative Complications | 1 | 2015 | 1033 | 0.080 |
Why?
| Diagnosis, Differential | 3 | 2019 | 1136 | 0.080 |
Why?
| Acetaminophen | 2 | 2023 | 349 | 0.080 |
Why?
| Lung Neoplasms | 1 | 2014 | 642 | 0.080 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 1213 | 0.080 |
Why?
| Anti-Bacterial Agents | 1 | 2013 | 820 | 0.070 |
Why?
| Mice | 3 | 2023 | 6413 | 0.070 |
Why?
| Animals | 4 | 2023 | 14385 | 0.060 |
Why?
| Liver | 2 | 2022 | 1225 | 0.060 |
Why?
| Contrast Media | 2 | 2015 | 221 | 0.060 |
Why?
| Rats | 2 | 2022 | 3415 | 0.060 |
Why?
| Alanine | 1 | 2023 | 44 | 0.060 |
Why?
| Pyruvic Acid | 1 | 2023 | 24 | 0.060 |
Why?
| Recurrence | 2 | 2015 | 690 | 0.060 |
Why?
| Glutathione | 1 | 2023 | 330 | 0.050 |
Why?
| Oxidation-Reduction | 1 | 2023 | 382 | 0.050 |
Why?
| Amphetamine | 1 | 2022 | 42 | 0.050 |
Why?
| Half-Life | 1 | 2022 | 92 | 0.050 |
Why?
| Antioxidants | 1 | 2023 | 297 | 0.050 |
Why?
| Duodenoscopy | 1 | 2020 | 2 | 0.050 |
Why?
| Drug Monitoring | 1 | 2020 | 85 | 0.050 |
Why?
| Adenosylhomocysteinase | 1 | 2020 | 11 | 0.050 |
Why?
| Alcohol Dehydrogenase | 1 | 2020 | 31 | 0.050 |
Why?
| Aldehyde Dehydrogenase | 1 | 2020 | 27 | 0.050 |
Why?
| Ileum | 1 | 2020 | 102 | 0.050 |
Why?
| Colonoscopy | 1 | 2020 | 105 | 0.050 |
Why?
| Blastomyces | 1 | 2019 | 30 | 0.040 |
Why?
| Epithelial Cells | 1 | 2021 | 255 | 0.040 |
Why?
| Young Adult | 2 | 2020 | 4308 | 0.040 |
Why?
| Drug Overdose | 1 | 2020 | 154 | 0.040 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2018 | 53 | 0.040 |
Why?
| Oxidative Stress | 1 | 2023 | 958 | 0.040 |
Why?
| Dexamethasone | 1 | 2020 | 435 | 0.040 |
Why?
| Cell Movement | 1 | 2018 | 271 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2020 | 1084 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2018 | 418 | 0.040 |
Why?
| Adolescent | 2 | 2020 | 6885 | 0.040 |
Why?
| Antifungal Agents | 1 | 2019 | 363 | 0.030 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 8 | 0.030 |
Why?
| Anastomosis, Surgical | 1 | 2015 | 72 | 0.030 |
Why?
| Image Enhancement | 1 | 2015 | 56 | 0.030 |
Why?
| Ultrasonography, Doppler | 1 | 2015 | 57 | 0.030 |
Why?
| Pancreas | 1 | 2015 | 80 | 0.030 |
Why?
| Organometallic Compounds | 1 | 2015 | 47 | 0.030 |
Why?
| Eye Infections, Bacterial | 1 | 2015 | 35 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2018 | 806 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 913 | 0.030 |
Why?
| Postoperative Care | 1 | 2015 | 121 | 0.030 |
Why?
| Prospective Studies | 1 | 2021 | 2604 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2020 | 1999 | 0.030 |
Why?
| Models, Biological | 1 | 2018 | 823 | 0.030 |
Why?
| Blepharoplasty | 1 | 2014 | 12 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2018 | 1550 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2015 | 923 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2018 | 1639 | 0.030 |
Why?
| Signal Transduction | 1 | 2018 | 1753 | 0.020 |
Why?
| Infant, Newborn | 1 | 2014 | 2907 | 0.020 |
Why?
| Infant | 1 | 2014 | 3817 | 0.020 |
Why?
|
|
Allard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|